A veteran global executive and dealmaker with broad commercial expertise and a record of strategic transformation in Fortune 500 companies, venture backed, financial, consumer- and healthcare companies.

Background in Executive and Non-Executive positions in family companies blending this experience with focus and understanding of the PE and Corporate and investment community.

She served on boards of multinationals like Aon Risk Solution, Reed Elsevier, and Royal Philips Electronics.

Currently holds an executive board position in Turn Biotechnologies a startup venture in Silicon Valley.

Bots has a degree in Economics from Fontys University of Applied Sciences in Eindhoven, Netherlands, and she has studied at Erasmus University in Rotterdam and Babson College in Boston.  She is a native Dutch speaker, and is fluent in English, German, French, Spanish and Italian.

Her personal talent lies in connecting people, building ’first in class’ teams, relevant networks and ecosystems.

“I’m excited and honored to apply my experience at Delta Diagnostics in their SVB , which embraces cutting edge and break- away innovation, to help it fulfill the unmet medical needs around the world.”